Luisa Sánchez-Lorenzo

7PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 18, 2024
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial.

Antonio González-Martín, María Jesús Rubio, Florian Heitz

|Aug 17, 2024
SENECA study: staging endometrial cancer based on molecular classification.

Enrique Chacon, Felix Boria, R Rajagopalan Lyer

|Apr 01, 2024
Management challenges in low-grade serous ovarian cancer with a BRCA mutation.

Luisa Sanchez-Lorenzo, Lidia Sancho, Teresa Iscar

|Mar 13, 2024
An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial).

Luis Chiva, Pilar Ordás, Nerea Martin-Calvo

|Dec 29, 2022
Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study.

Zaida Garcia-Casado, Ana Oaknin, Marta Mendiola

|Apr 23, 2022
Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network.

José Antonio López-Guerrero, Marta Mendiola, José Alejandro Pérez-Fidalgo

Pageof 2

Frequent Collaborators

3 joint publications

Luis Chiva

3 joint publications

Antonio González-Martín

2 joint publications

Jose Angel Minguez

2 joint publications

Nabil Manzour